Studies using CRISPR/Cas9 screening to identify genes in AML cells that are susceptible to DNT treatment have shown that inactivation of CD64 leads to resistance in AML and that the expression level of CD46 is associated with the AML cell susceptibility to DNT correlated.314. The gene discussed is FCGR1A; the disease is acute myeloid leukemia.